Watch the interview with CLS vd Dan Mogren below:
The medical technology company Clinical Laserthermia Systems is experiencing strong momentum and in order to build on it, it is now conducting a rights issue of SEK 69,3 million. CLS CEO Dan Mogren visited the BioStock studio to tell more about the issue and the upcoming FDA announcement that could advance the company's position in the American market.